[1]
Dr. Shivananda Murgod E, Dr Sumaira Ahmed, Dr Ahmed Shoqueer, Dr. Majed Alharbi, Dr Nawaf Almutairi and Dr. Abdullah Alqifari 2023. EFFICACY OF SOFOSBUVIR/DACLATASVIR IN CIRRHOTIC AND NON-CIRRHOTIC PATIENTS WITH HCV GENOTYPE 4 INFECTION AT A SPECIALIST HOSPITAL. Journal of Population Therapeutics and Clinical Pharmacology. 30, 18 (Nov. 2023), 2818–2823. DOI:https://doi.org/10.53555/jptcp.v30i18.3544.